Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

477.92
+19.114.17%
Post-market: 475.01-2.9100-0.61%19:43 EST
Volume:1.62M
Turnover:768.17M
Market Cap:121.26B
PE:33.60
High:478.28
Open:459.69
Low:459.00
Close:458.81
52wk High:519.68
52wk Low:362.50
Shares:253.72M
Float Shares:253.72M
Volume Ratio:1.34
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):14.22
EPS(LYR):-2.0768
ROE:22.31%
ROA:12.04%
PB:7.00
PE(LYR):-230.13

Loading ...

Earning Preview: Vertex Pharmaceuticals this quarter’s revenue is expected to increase by 14.16%, and institutional views are bullish

Earnings Agent
·
Feb 05

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
12 hours ago

WuXi Biologics Alliances Deepen Role In Complex Autoimmune And Fusion Drugs

Simply Wall St.
·
Yesterday

Prestige Consumer Healthcare Q3 2026 revenue at USD 283.4 million, down 2.4%

Reuters
·
Feb 05

Does WuXi Trispecific T-cell Engager Deal Reshape the Bull Case for Vertex Pharmaceuticals (VRTX)?

Simply Wall St.
·
Feb 05

Vertex Minerals Lifts High-Grade Output as Reward Gold Mine Ramps Up Underground Stoping

TIPRANKS
·
Feb 05

Vertex Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Feb 04

Vertex Pharmaceuticals Files Initial Statement of Beneficial Ownership for Mark E. Bunnage, EVP and Chief Scientific Officer

Reuters
·
Feb 04

Vertex Report: U.S. Sees Record-Level Growth in Sales Tax Rates and Rules Changes in 2025 Amid Fiscal Uncertainty

GlobeNewswire
·
Feb 03

Piper Sandler Downgrades Vertex to Neutral From Overweight

MT Newswires Live
·
Feb 03

Vertex Cut to Neutral From Overweight by Piper Sandler

Dow Jones
·
Feb 03

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Brookdale Senior Living (BKD)

TIPRANKS
·
Feb 03

WuXi Biologics schließt Lizenz- und Forschungsdienstleistungsvertrag mit Vertex Pharmaceuticals für T-Zell-Engager ab

Reuters
·
Feb 03

Vertex Minerals Reaffirms JORC-Compliant Gold Resource Position at Reward Mine

TIPRANKS
·
Feb 03

Vertex Minerals Strengthens Leadership to Drive Reward Gold Mine Production Ramp-Up

TIPRANKS
·
Feb 02

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Jan 31

Vertex Ramps Up Underground Production at Reward Gold Mine and Bolsters Funding

TIPRANKS
·
Jan 30

Assessing Vertex Pharmaceuticals (VRTX) Valuation After Fund Exit And Setback For Journavx Pain Label

Simply Wall St.
·
Jan 29

Satellos Bioscience Appoints Antoinette Paone as Chief Development Officer

Reuters
·
Jan 29

Vertex Pharmaceuticals Raised to Overweight From Equal-Weight by Barclays

Dow Jones
·
Jan 28